Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What Interactive Strength TRNR is doing that separates it from the herd Technical Weakness 20260507 Broadridge BR Operational Review Q1 2026 Profit Surprises GMED Globus Medical Inc posts Q4 2025 EPS beat and 166 percent revenue growth shares dip modestly Nike Inc NKE Licensed Sports Merchandise Market Expansion Presents Strategic Growth Opportunities Through 2034 SSAC SPACSphere management highlights merger pipeline progress and key target verticals for its planned business combination Mint MIMI Stock Trailing Stop Trend Weakens 20260420 NetEase Inc NTES Trump Warns Taiwan Against Independence Amid Summit with Xi Jinping Lionheart CUBWW Flat at 017 Consolidation Continues 20260515 TrumpXi Summit This Week Key Market Watchpoints for Asia Aldeyra ALDX Q1 2026 Earnings Why the Beat Matters Rhythm Pharmaceuticals RYTM Stock Down 407 Support Test at 8250 20260518 CitizensBanc CZWI Down 167 How Low Could It Go 20260517 Analysts Offer Mixed Views on CVS Healths Outlook Vegorama Punjabi Angithi IPO Allotment Expected Today After 35x Subscription Astera Labs Shares Surge 32 Following Bullish Analyst Coverage Walmarts NonRetail Arm Emerges as Growth Engine but Premium Valuation Demands Proof Treasury Yield Surge Challenges RiskFree Status Pushing Investors Toward HigherYielding Bonds Jim Cramer Recommends Two Stocks Highlights Nearly 20 Upside Potential MRCC Q4 2025 Earnings EPS Surges Past Estimates with 1983 Beat CRDO Q1 2026 Earnings EPS Surpasses Estimates by 98 Shares Rally OPXS Q1 2026 Earnings Positive EPS Amid Modest Revenue Challenges NOV Q1 2026 Earnings EPS Misses Estimates Sharply as Revenue Details Remain Unreported HealthEquity Q1 2026 Earnings EPS Beats Estimates Stock Rises 194 CLDI Q4 2025 Earnings Smallerthanexpected loss highlights progress in clinicalstage biotherapeutics Kymera Therapeutics KYMR Holds Steady at 8136 as Investors Weigh Support and Resistance Levels Philip Morris International Edges Lower as Stock Consolidates Near Key Levels Fate Therapeutics Rallies 95 as FATE Stock Breaks Above Key Support Level Merit Medical Systems MMSI Edges Higher Testing Resistance Near 68 Rocky Brands RCKY Posts 324 Gain Is a Breakout Toward Resistance Underway